Form 13-F position report

ARGENX SE

Reported by ORBIMED ADVISORS LLC

ARGX CUSIP 04016X101 Manager CIK 0001055951

Reported 75,180 shares, down 17,700 (19.1%) from the prior quarter.

Reported value -16.3%; share count -19.1% vs. the prior quarter.

Reduced
% of reported 13F value 1.32% This manager · Q3 2026
Shares 75,180 Quarter-end amount reported
Reported value $72,090,854 Fair value at quarter end
Consecutive quarters held 19 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 53540000
2022-06-30 73503000
2022-09-30 95218000
2022-12-31 6137046
2023-03-31 16579810
2023-06-30 12705198
2023-09-30 16027138
2023-12-31 32184378
2024-03-31 59687952
2024-06-30 89921364
2024-09-30 110855360
2024-12-31 116665500
2025-03-31 122338496
2025-06-30 114653760
2025-09-30 127081588
2025-12-31 122778700
2026-03-31 99971225
2026-06-30 86171278
2026-09-30 72090854

Quarterly position history

How this manager's reported quarter-end position changed over time.

19 quarters
Quarterly reported position history for ARGENX SE held by ORBIMED ADVISORS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 75,180 -17,700 (-19.1%) 1.32% $72,090,854 2026-11-16
Q2 2026 Reduced 92,880 -44,020 (-32.2%) 1.61% $86,171,278 2026-08-14
Q1 2026 Reduced 136,900 -9,100 (-6.2%) 1.99% $99,971,225 2026-05-15
Q4 2025 Reduced 146,000 -26,300 (-15.3%) 2.52% $122,778,700 2026-02-17
Q3 2025 Reduced 172,300 -35,700 (-17.2%) 3.0% $127,081,588 2025-11-14
Q2 2025 Added 208,000 +1,300 (0.6%) 2.87% $114,653,760 2025-08-14
Q1 2025 Added 206,700 +17,000 (9.0%) 2.93% $122,338,496 2025-05-15
Q4 2024 Reduced 189,700 -14,800 (-7.2%) 2.41% $116,665,500 2025-02-14
Q3 2024 Reduced 204,500 -4,600 (-2.2%) 2.02% $110,855,360 2024-11-14
Q2 2024 Added 209,100 +57,500 (37.9%) 1.79% $89,921,364 2024-08-14
Q1 2024 Added 151,600 +67,000 (79.2%) 1.1% $59,687,952 2024-05-15
Q4 2023 Added 84,600 +52,000 (159.5%) 0.65% $32,184,378 2024-02-14
Q3 2023 Unchanged 32,600 0 (0.0%) 0.34% $16,027,138 2023-11-14
Q2 2023 Reduced 32,600 -11,900 (-26.7%) 0.23% $12,705,198 2023-08-14
Q1 2023 Added 44,500 +28,300 (174.7%) 0.33% $16,579,810 2023-05-15
Q4 2022 Reduced 16,200 -253,500 (-94.0%) 0.12% $6,137,046 2023-02-14
Q3 2022 Added 269,700 +75,700 (39.0%) 1.79% $95,218,000 2022-11-14
Q2 2022 Added 194,000 +24,200 (14.3%) 1.35% $73,503,000 2022-08-15
Q1 2022 New 169,800 +169,800 (0.0%) 0.88% $53,540,000 2022-05-16
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

596 managers reported ARGENX SE for Q3 2026.

Managers reporting ARGENX SE in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 5,357,529 +126,077 0.22% $5,137,388,244 38 qtrs
JANUS HENDERSON GROUP PLC Reduced 2,391,136 -150,596 0.97% $2,293,070,610 1 qtr
Capital World Investors Added 2,279,203 +79,433 0.27% $2,185,633,912 31 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 2,239,720 -438,327 0.22% $2,147,691,000 38 qtrs
Artisan Partners Limited Partnership Reduced 1,165,747 -343,031 2.04% $1,117,840,003 33 qtrs
Avoro Capital Advisors LLC Unchanged 1,000,000 0 9.89% $958,910,000 38 qtrs
BlackRock Inc Added 879,255 +102,018 0.01% $843,126,343 9 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 715,939 -214,609 0.12% $686,521,066 28 qtrs
RTW INVESTMENTS LP Added 711,584 +2,138 6.88% $682,345,013 38 qtrs
MORGAN STANLEY Reduced 586,527 -56,596 0.03% $562,428,821 38 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
SPONSORED ADR

Voting authority reported

Sole
0
Shared
0
None
75,180

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.